These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9051718)

  • 21. Myocardial ischemia-mediated excitatory reflexes: a new function for thromboxane A2?
    Fu LW; Phan A; Longhurst JC
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2530-40. PubMed ID: 18952714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatment.
    Grover GJ; Fulmor IE
    J Pharmacol Exp Ther; 1988 Nov; 247(2):445-52. PubMed ID: 3183946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboxane A2 receptor mediation of calcium and calcium transients in rat cardiomyocytes.
    Dogan S; Turnbaugh D; Zhang M; Cofie DQ; Fugate RD; Kem DC
    Life Sci; 1997; 60(12):943-52. PubMed ID: 9061051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
    Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
    Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
    Golino P; Ashton JH; McNatt J; Glas-Greenwalt P; Yao SK; O'Brien RA; Buja LM; Willerson JT
    Circulation; 1989 Apr; 79(4):911-9. PubMed ID: 2494005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of thromboxane actions in the isolated perfused rat heart.
    Stahl GL; Darius H; Lefer AM
    Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock.
    Patel JP; Beck LD; Briglia FA; Hock CE
    Crit Care Med; 1995 Feb; 23(2):231-7. PubMed ID: 7867347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Faggiotto A; Caputi AP
    Agents Actions; 1993 Jul; 39(3-4):143-9. PubMed ID: 8304242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.
    O'Keefe EH; Liu EC; Greenberg R; Ogletree ML
    Prostaglandins; 1985 May; 29(5):785-97. PubMed ID: 3925501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboxane A2 receptor antagonism prevents hormonal and cardiovascular responses to mineral acid infusion.
    Cudd TA; Wood CE
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1235-40. PubMed ID: 7977850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboxane receptor blockade with SQ 30,741 improves post-ischemic myocardial function in anesthetized dogs.
    Grover GJ
    Proc Soc Exp Biol Med; 1989 Oct; 192(1):56-60. PubMed ID: 2529546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
    J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activator.
    Grover GJ; Parham CS; Schumacher WA
    Am Heart J; 1991 Feb; 121(2 Pt 1):426-33. PubMed ID: 1825008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
    Brezinski ME; Yanagisawa A; Darius H; Lefer AM
    Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of thromboxane receptor blockade on oxygen supply/consumption variables during reperfusion in the anesthetized dog.
    Grover GJ; Sleph PG; Weiss HR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1097-102. PubMed ID: 2141635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of halothane anesthesia on myocardial necrosis, hemodynamic performance, and regional myocardial blood flow in dogs following coronary artery occlusion.
    Davis RF; DeBoer LW; Rude RE; Lowenstein E; Maroko PR
    Anesthesiology; 1983 Nov; 59(5):402-11. PubMed ID: 6638546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.
    Dubé GP; Jakubowski JA; Brune KA; Bemis KG; Kurtz WL
    J Pharmacol Exp Ther; 1995 Feb; 272(2):799-807. PubMed ID: 7853197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs.
    Imamoto T; Terashita Z; Tanabe M; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1986; 8(4):832-9. PubMed ID: 2427826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction of ischaemic brain acidosis with SQ29,548/1-benzylimidazole.
    Pettigrew LC; Hazle JD; Gutierrez G; Smith CD; Ogletree ML
    Neurol Res; 1992 Sep; 14(4):335-9. PubMed ID: 1360630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.